SAB Biotherapeutics
0 followers
‌
SAB Biotherapeutics is advancing a new class of immunotherapies with targeted, fully human polyclonal antibodies for the treatment of Covid-19, diabetes, organ transplant & flu.
Industries
Headquarters
Employees
Links
Org chart
Eddie J. Sullivan
Co-Founder, President & CEO
Eddie J. Sullivan
Collapse
Christoph Bausch
Executive Vice President & Chief Operating Officer
Alexandra Kropotova
EVP, Chief Medical Officer
Dr. Carlos Carrillo, MS, PhD.
SVP Of Regulatory Affairs/quality Assurance At SAB Biotherapeutics
Jacob Spade
Senior Director Human Resources
Angela Parizek
Vice President, Clinical Operations
Trenton Klimper
Executive Director of Financial Reporting
